首页> 美国卫生研究院文献>Lipids in Health and Disease >A soy-based phosphatidylserine/ phosphatidic acid complex (PAS) normalizes the stress reactivity of hypothalamus-pituitary-adrenal-axis in chronically stressed male subjects: a randomized placebo-controlled study
【2h】

A soy-based phosphatidylserine/ phosphatidic acid complex (PAS) normalizes the stress reactivity of hypothalamus-pituitary-adrenal-axis in chronically stressed male subjects: a randomized placebo-controlled study

机译:大豆基磷脂酰丝氨酸/磷脂酸复合物(PAS)使慢性应激男性受试者下丘脑-垂体-肾上腺轴的应激反应正常化:一项随机安慰剂对照研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundSupplementation with a phosphatidylserine and phosphatidylserine/ phosphatidic acid complex (PAS) has been observed to normalize stress induced dysregulations of the hypothalamus-pituitary-adrenal axis (HPAA). Prolonged stress first induces a hyper-activation of the HPAA, which then can be followed by a state of hypo-activation.The aim of this study was to examine effects of an oral supplementation with 400 mg PS & 400 mg PA (PAS 400) per day on the endocrine stress response (ACTH, saliva and serum cortisol) to a psychosocial stressor. A special focus was to analyze subgroups of low versus high chronically stressed subjects as well as to test efficacy of 200 mg PS & 200 mg PA (PAS 200).
机译:背景技术已观察到补充磷脂酰丝氨酸和磷脂酰丝氨酸/磷脂酸复合物(PAS)可使下丘脑-垂体-肾上腺轴(HPAA)应激引起的失调正常化。长时间的压力首先会引起HPAA的过度激活,然后可能是过度激活状态。本研究的目的是研究口服400 mg PS和400 mg PA(PAS 400)的补充剂的作用每天对心理社会应激源的内分泌应激反应(ACTH,唾液和血清皮质醇)。一个特别的重点是分析低压力和高慢性压力受试者的亚组,以及测试200 mg PS和200 mg PA(PAS 200)的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号